Pathology Watch
Digital dermatopathology from biopsy to diagnosis
May
2020
Company Event
$5M Series A
Jan
2021
Company Event
$25M Series B
Nov
2021
Frazier Event
Frazier VC primary Series B investment
Nov
2023
Company Event
Acquired by Sonic Healthcare for $130M
Capital Events Timeline
Company Overview
PathologyWatch provides an end-to-end digital dermatopathology platform that digitizes skin biopsy workflows, integrates with clinic EMRs, and supports remote review.
Why We Invested
PathologyWatch delivers an integrated end-to-end platform connecting lab systems, digital viewing, and EMR interfacing in a single clinical workflow.
Investment Vehicle
Frazier Family Investment
Investor
Frazier VC
Founded
2017
Sector
Healthcare & Life Sciences
Legal Name
PathologyWatch
Status
Realized
Other Investors
Ceros Capital Markets, Rock Creek Capital, SpringTide Investments, Spark Growth Ventures, Blueprint Health, Blackbrook Management Group